The Law Offices of Matthew J. Quinlan are currently filing lawsuits on behalf of California women who have suffered injuries related to vaginal mesh complications...(PRWeb August 02, 2012)Read the full story at http://www.prweb.com/releases/2012/8/prweb9761600.htm (Source: PRWeb: Medical Pharmaceuticals)MedWorm Sponsor Message: Please support the Doctors In Chains campaign for the medics tortured and sentenced for up to 15 years in Bahrain. #FreeDoctors read more..
Showing posts with label Pharmaceuticals. Show all posts
Showing posts with label Pharmaceuticals. Show all posts
Sunday, 5 August 2012
California Women-Pharmaceuticals-Transvaginal-Prweb
MJQLAW Filing Lawsuits on Behalf of Women Injured By Transvaginal Mesh
source:http://www.medworm.com
Thursday, 19 April 2012
Pharmaceutical Company-Sales And Marketing-Michael Sullivan-Pharmaceuticals-Women's Health
Avion Pharmaceuticals, LLC Names Michael Sullivan as new VP, Sales and Marketing
ATLANTA, April 18, 2012 (HSMN NewsFeed) -- Avion Pharmaceuticals, LLC, a specialty pharmaceutical company focused in Women's Health, recently announced the appointment of Michael Sullivan as Vice President, Sales and Marketing. Sullivan will be responsi... Biopharmaceuticals, Dermatology, PersonnelAvion Pharmaceuticals (Source: HSMN NewsFeed)MedWorm Sponsor Message: Please have a look at this new site driven by MedWorm: The Breast Cancer Daily read more..
source:http://www.medworm.com
Thursday, 15 March 2012
Pharmaceutical Manufacturing-Pharmaceutical Companies-President Barack Obama-Republican Candidates
Lobbying by Pharmaceutical Manufacturing | OpenSecrets
Pharmaceutical Manufacturing
Pharmaceutical companies, which develop both over-the-counter and prescription drugs, have been among the biggest political spenders for years. While the industry has traditionally supported Republican candidates, some key players have recently increased donations to Democratic candidates as the GOP’s power in Washington erodes. The pharmaceutical manufacturing industry will likely fair better this decade now that President Barack Obama’s initial plan to institute a public health insurance did not become a part of sweeping health care reform legislation signed into law in 2010. A government-run plan, because of its size, would have had considerable negotiating power to draw down drug prices. [Read more Background]Top Contributors, 2011-2012
ContributorAmountPfizer Inc $702,391Amgen Inc $574,648AstraZeneca PLC $527,501Abbott Laboratories $406,773Merck & Co $363,041GlaxoSmithKline $325,741Eli Lilly & Co $264,762Novartis AG $205,209Bayer Corp $124,650Endo Pharmaceuticals $116,400Perrigo Co $111,475Mutual Pharmaceutical $105,000Allergan Inc $88,000Teva Pharmaceuticals USA $86,870Sanofi-Aventis $78,300Bristol-Myers Squibb $70,050Pharmaceutical Rsrch & Mfrs of America $65,450Nostrum Pharmaceuticals $62,300Cephalon Inc $61,250Takeda Pharmaceuticals North America $61,250...view more ContributorsContribution Trends, 1990-2010
...view TotalsLobbying Totals, 1998-2010
...view more LobbyingParty Split, 1990-2010
Top Recipients, 2011-2012
CandidateOfficeAmountObama, Barack (D) $129,139Romney, Mitt (R) $89,300Upton, Fred (R-MI)House $77,575Brown, Scott P (R-MA)Senate $76,483Hatch, Orrin G (R-UT)Senate $69,400...view more RecipientsAverage Contributions to Members of Congress, 1990-2010
...view more Money to Congress Data for the current election cycle were released by the Federal Election Commission on Monday, February 13, 2012 Feel free to distribute or cite this material, but please credit the Center for Responsive Politics. via opensecrets.org Posted via email from Jack's posterous read more..
Subscribe to:
Posts (Atom)